ORASIS in Breast Reconstruction
NCT: NCT07670754 · NOT_YET_RECRUITING
Brief Summary
The purpose of this study is to assess the use of ORASIS during microsurgical anastomosis formation in Deep Inferior Epigastric Perforator (DIEP) flap breast reconstruction and its potential effects on surgical precision, surgeon efficiency, and anastomosis outcomes. The investigators hypothesize that the use of ORASIS will decrease the amount of time needed to perform microsurgical anastomoses, reduce interruptions for irrigation and suction, and increase the quality of anastomoses in DIEP flap breast reconstruction.
Frequently Asked Questions
What is ORASIS in Breast Reconstruction?
ORASIS in Breast Reconstruction is a clinical trial registered under NCT07670754. Current status: NOT_YET_RECRUITING.
What is the status of NCT07670754?
The current status of NCT07670754 (ORASIS in Breast Reconstruction) is: NOT_YET_RECRUITING.
When did ORASIS in Breast Reconstruction start?
ORASIS in Breast Reconstruction started on 2026-12.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.